Hostname: page-component-848d4c4894-wzw2p Total loading time: 0 Render date: 2024-05-01T02:16:31.713Z Has data issue: false hasContentIssue false

Re: Estimating the cost of inappropriate antibiotic prophylaxis prior to dental procedures

Published online by Cambridge University Press:  03 November 2023

Craig S. Miller*
Affiliation:
Department of Oral Health Practice, Center for Oral Health Research, University of Kentucky, College of Dentistry, Lexington, Kentucky, United States
Martin H. Thornhill
Affiliation:
Academic Unit of Oral & Maxillofacial Medicine Surgery & Pathology, University of Sheffield School of Clinical Dentistry, Claremont Crescent, Sheffield, United Kingdom
*
Corresponding author: Craig S. Miller; Email: cmiller@uky.edu
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

To the Editor—We would like to comment on the paper by Gong et al, “Estimating the cost of inappropriate antibiotic prophylaxis prior to dental procedures.” Reference Gong, Duong and Zangwill1 We agree that significant overprescribing of antibiotic prophylaxis occurs in patients for whom it is not recommended. A recent study of US patients with employer provided medical/dental insurance coverage found that 9.5% of patients at moderate infective endocarditis risk and 2.9% of patients at low risk were prescribed antibiotic prophylaxis when undergoing invasive dental procedures (IDPs) despite this not being recommended by American Heart Association (AHA) guidelines. Reference Thornhill, Gibson and Yoon2 Similar figures were reported for those on Medicaid (10.5% and 3.8%, respectively). Reference Thornhill, Gibson and Yoon3 As suggested by Gong et al, Reference Gong, Duong and Zangwill1 significant cost is associated with this overprescribing.

These researchers, however, did not address another and perhaps more important aspect of inappropriate antibiotic prophylaxis prescribing by dentists. The AHA guidelines recommend that all patients at high risk from infective endocarditis should receive antibiotic prophylaxis before undergoing IDPs. Reference Wilson, Gewitz and Lockhart4 However, in a 2020 US study, 64% of IDPs were unlikely to have been covered with antibiotic prophylaxis in patients at high risk of developing infective endocarditis complications. Reference Thornhill, Gibson and Durkin5 More recently, Thornhill et al Reference Thornhill, Gibson and Yoon2 found that only 32.6% of high-risk US patients with employer-provided medical/dental insurance received antibiotic prophylaxis when undergoing an IDP. And in a 2023, another study reported that only 25.9% of high-risk Medicaid patients received antibiotic prophylaxis before IDPs. Reference Thornhill, Gibson and Yoon3 These 2 studies further demonstrated that antibiotic prophylaxis significantly reduced the subsequent risk of infective endocarditis for high-risk patients undergoing IDPs, particularly dental extractions and oral surgery procedures. Reference Thornhill, Gibson and Yoon2,Reference Thornhill, Gibson and Yoon3 Indeed, the numbers of IDPs of all types combined, extractions and oral surgery procedures, that need to be covered by antibiotic prophylaxis to prevent 1 case of infective endocarditis (ie, the number needed to prevent) were 1,536, 125, and 45, respectively, for those with employer provided medical/dental cover Reference Thornhill, Gibson and Yoon2 and 244, 143, and 71, respectively, for Medicaid patients. Reference Thornhill, Gibson and Yoon3

The failure to prescribe antibiotic prophylaxis for ∼65% of patients for whom it is recommended places a significant number of patients at unnecessary risk of developing infective endocarditis, with all its consequences. Infective endocarditis is a devastating infection of the heart valves with ∼30% first-year mortality. Reference Cahill and Prendergast6 Patients require extended hospital admissions often involving intensive care and long courses of antibiotics, and ∼50% of these patients require surgical replacement of 1 or more heart valves. Reference Cahill and Prendergast6 Stroke, heart failure, kidney failure, and brain abscess are common complications, and those who survive frequently have ongoing complications and disabilities that affect their ability to work and function. Reference Cahill and Prendergast6 The cost of failure to prescribe antibiotic prophylaxis is, therefore, extremely high, not just to the healthcare system but also for affected individuals, their families, and society. Reference Franklin, Wailoo and Dayer7 These costs are likely to substantially exceed the costs of overprescribing antibiotic prophylaxis.

Our concern is that focusing only on inappropriate overprescribing, with the implicit message that antibiotic prophylaxis prescribing should be reduced, could exacerbate the underprescribing of antibiotic prophylaxis to those who should receive it.

Under- and overprescribing represent 2 different facets of inappropriate antibiotic prophylaxis dental prescribing. The extents of both are serious causes for concern, and both urgently need to be addressed through educational and antibiotic stewardship programs aimed at reducing both under- and overprescribing of antibiotic prophylaxis by dentists. In particular, efforts need to ensure the correct targeting of antibiotic prophylaxis to high-risk patients only undergoing IDPs, according to the AHA guidelines. Reference Wilson, Gewitz and Lockhart4 Correct antibiotic prophylaxis targeting would reduce the huge financial and personal costs of unnecessary infective endocarditis cases that result from a failure to prescribe antibiotic prophylaxis for those who need it (not mentioned in this article) Reference Franklin, Wailoo and Dayer7 as well as the unnecessary cost and risks associated with prescribing antibiotic prophylaxis for those who do not need it. Reference Gong, Duong and Zangwill1

Acknowledgments

Financial support

No financial support was provided relevant to this article.

Competing interests

All authors report no conflicts of interest relevant to this article.

References

Gong, CL, Duong, A, Zangwill, KM. Estimating the cost of inappropriate antibiotic prophylaxis prior to dental procedures. Infect Control Hosp Epidemiol 2023:14. doi: 10.1017/ice.2023.126.Google ScholarPubMed
Thornhill, MH, Gibson, TB, Yoon, F, et al. Antibiotic prophylaxis against infective endocarditis before invasive dental procedures. J Am Coll Cardiol 2022;80:10291041.CrossRefGoogle ScholarPubMed
Thornhill, MH, Gibson, TB, Yoon, F, et al. Endocarditis, invasive dental procedures, and antibiotic prophylaxis efficacy in US Medicaid patients. Oral Dis 2023. doi: 10.1111/odi.14585.CrossRefGoogle Scholar
Wilson, WR, Gewitz, M, Lockhart, PB, et al. Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. Circulation 2021;143:e963e978.CrossRefGoogle ScholarPubMed
Thornhill, MH, Gibson, TB, Durkin, MJ, et al. Prescribing of antibiotic prophylaxis to prevent infective endocarditis. JADA 2020;151:835845.Google ScholarPubMed
Cahill, TJ, Prendergast, BD. Infective endocarditis. Lancet 2015;387:882893.CrossRefGoogle ScholarPubMed
Franklin, M, Wailoo, A, Dayer, M, et al. The cost-effectiveness of antibiotic prophylaxis for patients at risk of infective endocarditis Circulation 2016;134:15681578.CrossRefGoogle ScholarPubMed